Novocure Ltd. (NVCR): Price and Financial Metrics
NVCR Price/Volume Stats
| Current price | $16.86 | 52-week high | $24.74 |
| Prev. close | $16.48 | 52-week low | $11.29 |
| Day low | $16.22 | Volume | 673,900 |
| Day high | $17.35 | Avg. volume | 1,284,845 |
| 50-day MA | $16.52 | Dividend yield | N/A |
| 200-day MA | $17.11 | Market Cap | 1.82B |
NVCR Stock Price Chart Interactive Chart >
Novocure Ltd. (NVCR) Company Bio
NovoCure Limited is a commercial stage oncology company which develops treatment for solid tumor cancers therapy called the tumor treating fields. The company was founded in 2000 and is based in Saint Helier, Channel Islands.
NVCR Price Returns
| 1-mo | 4.40% |
| 3-mo | -6.44% |
| 6-mo | -27.17% |
| 1-year | 41.44% |
| 3-year | -82.62% |
| 5-year | -82.03% |
| YTD | 12.93% |
| 2023 | -79.65% |
| 2022 | -2.30% |
| 2021 | -56.61% |
| 2020 | 105.34% |
| 2019 | 151.70% |
Continue Researching NVCR
Want to do more research on NovoCure Ltd's stock and its price? Try the links below:NovoCure Ltd (NVCR) Stock Price | Nasdaq
NovoCure Ltd (NVCR) Stock Quote, History and News - Yahoo Finance
NovoCure Ltd (NVCR) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...